- Bydureon pen gets FDA approval
- Perrigo recalls APAP infant suspension liquid due to the possibility of missing dose markings on the dosing syringe
- New study suggests blood pressure should be measured in both arms
- PharmaSupply introduces NeedleBay insulin pen organizer
- Unilife, Hikma enter $40 million partnership
PALM BEACH GARDENS, Fla. — AccuDial Pharmaceutical earlier this month announced it has developed a new patent-pending line of child-proof container enclosure systems, designed to reduce the accidental or unsupervised ingestion of liquid over-the-counter and prescription medications.
One of AccuDial's new patent-pending designs is an innovative safety cap and oral dosing syringe system. The safety cap is permanently fastened to the container and includes an integrated one-way valve for accessing medication with an accompanying oral syringe, and a flip-top lid that covers the valve when the product is not in use.
An unsupervised child is unable to remove the safety cap or otherwise access the liquid inside the container without utilizing the oral syringe, which is intended to be stored by the caregiver separately from the product. A child also is unable to suck or squeeze the liquid from the container because of the one-way valve, which prevents the flow of the medication without utilizing the oral syringe.
In a recent study of emergency department visits for unintentional pediatric poisonings between 2004 and 2005, 82% of the visits were due to the unsupervised ingestion of pharmaceutical products by children who accessed the medications on their own.